Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Sunday, May 3, 2020
Maryland Board of Pharmacy Guidance and Announcements Regarding COVID-19
Maryland Board of Pharmacy Guidance on FDA Temporary Compounding policy
April 22, 2020
Earlier this week the FDA issued temporary policy guidance on compounding of certain drugs for hospital patients by pharmacy compounders not registered as outsourcing facilities.
The Maryland Board of Pharmacy generally supports the policy. However, Maryland-licensed pharmacies that want to implement this temporary policy will be required to submit their request in writing to the board for consideration. Board authorization is required before any pharmacy may provide compounded products under the auspices of this FDA policy guidance.